Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 702

Long-Term Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement

Dr. David Cohen comments on 10-year results from a trial of transcatheter vs. surgical aortic valve replacement:

Over the past decade, transcatheter aortic valve replacement (TAVR) has evolved from a niche procedure to treat severe aortic stenosis in high-risk patients to a mainstream procedure that is also performed in intermediate-and low-risk patients. With this evolution in practice, the large number of younger patients with life expectancies 10 years now receiving TAVR has raised concerns about its durability and patients’ long-term outcomes. Now, 10-year results are available from the NOTION trial of TAVR versus surgical aortic valve replacement (SAVR) that was conducted between 2009 and 2013 (NEJM JW Cardiol May 29 2015 and J Am Coll Cardiol 2015; 65:2184).

Two hundred eighty patients aged 70 years (mean age, 79 years; mean predicted risk of surgical mortality, 3%) were randomized to SAVR using any commercially available bioprosthesis or TAVR using the first-generation self-expanding CoreValve device. At 10-year follow-up, there was no significant between-group difference in the composite of death, stroke, or myocardial infarction (66% for both groups) or any of the individual components. Rates of bioprosthetic valve failure and repeat valve intervention were also similar. However, the rate of bioprosthetic valve dysfunction was lower with TAVR, largely reflecting lower rates of patient–prosthesis mismatch. The rate of structural valve deterioration was lower with TAVR as well, driven mainly by lower transvalvular gradients with TAVR that emerged early and persisted throughout follow-up.

Although limited by its modest sample size, the NOTION trial provides the longest available follow-up of any TAVR-versus-SAVR randomized trial to date. Overall, the results provide reassurance that there are no important differences in major clinical outcomes between the two strategies, and the echocardiographic data suggest sustained differences in hemodynamic performance in favor of TAVR. Nonetheless, given the advanced age of the patients at the time of enrollment, we should be cautious in extrapolating these findings to younger patients with severe aortic stenosis or to patients with bicuspid aortic valve disease (who were excluded from NOTION). These findings emphasize the tension between ongoing innovation and the desire for long-term outcomes data for our cardiac devices.

Engineers 3D print the electromagnets at the heart of many electronics

Imagine being able to build an entire dialysis machine using nothing more than a 3D printer.

This could not only reduce costs and eliminate manufacturing waste, but since this machine could be produced outside a factory, people with limited resources or those who live in remote areas may be able to access this more easily.

While multiple hurdles must be overcome to develop that are entirely 3D printed, a team at MIT has taken an important step in this direction by demonstrating fully 3D-printed, three-dimensional solenoids.

Neuralink’s first human patient able to use mouse through thinking says Elon Musk | WION Originals

Neuralink’s first human patient able to use mouse…:

Elon Musk is the visionary behind Neuralink. He announced that the first human recipient of the company’s brain chip implant has fully recovered. The individual has demonstrated the ability to use a computer mouse solely through thoughts. Watch this video for all details.

#Neuralink #ElonMusk #WION

About Channel:

WION The World is One News examines global issues with in-depth analysis. We provide much more than the news of the day. Our aim is to empower people to explore their world. With our Global headquarters in New Delhi, we bring you news on the hour, by the hour. We deliver information that is not biased. We are journalists who are neutral to the core and non-partisan when it comes to world politics. People are tired of biased reportage and we stand for a globalized united world. So for us, the World is truly One.

Continue reading “Neuralink’s first human patient able to use mouse through thinking says Elon Musk | WION Originals” | >

Reducing Persistence of Antibiotic Resistance

In 1940, 12 years after Alexander Fleming discovered penicillin, microbiologists made a concerning discovery: a strain of the bacteria Escherichia coli had developed resistance to the new, life-saving drug. Antibiotic resistance of disease-causing bacteria is now a global problem, with bacteria continually evolving mechanisms that prevent such drugs from killing the organisms or inhibiting their growth. Now Vanderlei Bagnato of the University of São Paulo and his colleagues have developed a light-based approach that could help reduce this trend in a Staphylococcus bacterium that can cause skin infections and pneumonia [1]. The researchers presented their technique at the recent SPIE Photonics West 2024 conference in San Francisco.

If the current trend continues, epidemiologists predict that the number of people infected by antibiotic-resistant bacteria will reach 225 million worldwide by 2030. By 2050 these bacteria will cause 10 million deaths annually. Studies show that infections acquired in hospital are increasingly prone to this problem. “People are dying every day in [intensive care wards] from resistant bacteria. If someone acquires pneumonia, and antibiotics don’t work, they’re in trouble,” Bagnato says.

One route to tackling antibiotic resistance is to develop new drugs, which is a costly process. Another route—and one that is becoming increasingly popular—is to inhibit antibiotic-eluding mechanisms that a bacterium develops as it evolves. This inhibition can be achieved using light, a process those in the field call photodynamics, and the route Bagnato and his colleagues have taken. “We’re using photodynamics to reverse resistance so that antibiotics can act again,” he says.

Hiroshima fallout debris linked to first solar system condensates

The atomic bombing of Hiroshima, Japan, by the United States in August 1945 was not only devastating at the time, resulting in the deaths of hundreds of thousands of people, but it has had long-standing impacts to the present day, particularly the elevated incidence of cancer from radiation.

Continued research of Hiroshima Bay has uncovered a new kind of debris from the fallout, known as Hiroshima glasses. These formed from vaporized materials of the bomb and the surrounding landscape and infrastructure being targeted.

New research published in Earth and Planetary Science Letters has analyzed the chemical and isotopic compositions of these glasses to ascertain their formation process during the nuclear event.

Enhanced 3D chemical imaging with phase-modulation

Understanding complex biological and biomedical systems is greatly aided by 3D imaging, which provides much more detailed information than traditional two-dimensional methods. However, live cell and tissue imaging remain challenging due to factors like limited imaging speed and significant scattering in turbid environments.

In this context, multimodal microscopy techniques are notable. Specifically, nonlinear techniques like CRS (coherent Raman scattering) use optical vibrational spectroscopy, providing precise chemical imaging in tissues and cells in a label-free way.

Furthermore, stimulated Raman scattering (SRS) microscopy, a CRS method, can accurately capture images of biomolecules due to the linear relationship between stimulated Raman intensity and the concentration of target molecules. It does so with high sensitivity and without interference from unwanted nonresonant backgrounds.

Evading Bacterial Resistance: Scientists Develop Groundbreaking New Antibiotic

Researchers from the University of Illinois Chicago and Harvard University have created an antibiotic that may provide medicine a new tool to combat bacteria resistant to drugs and the illnesses they trigger.

The antibiotic, cresomycin, described in Science, effectively suppresses pathogenic bacteria that have become resistant to many commonly prescribed antimicrobial drugs.

The promising novel antibiotic is the latest finding for a longtime research partnership between the group of Yury Polikanov, associate professor of biological sciences at UIC, and colleagues at Harvard. The UIC scientists provide critical insights into cellular mechanisms and structure that help the researchers at Harvard design and synthesize new drugs.

Scientists Have Created the World’s Smallest, Lightest, and Fastest Fully Functional Micro-Robots

Two insect-like robots, a mini-bug and a water strider, developed at Washington State University, are the smallest, lightest and fastest fully functional micro-robots ever known to be created.

Such miniature robots could someday be used for work in areas such as artificial pollination, search and rescue, environmental monitoring, micro-fabrication, or robotic-assisted surgery. Reporting on their work in the proceedings of the IEEE Robotics and Automation Society’s International Conference on Intelligent Robots and Systems, the mini-bug weighs in at eight milligrams while the water strider weighs 55 milligrams. Both can move at about six millimeters a second.

/* */